ABUS Swing Viés de alta

Arbutus Biopharma CorporationNASDAQ

Descrição

⋅ 4 de Jan de 2021 20:08

ABUS have a high evaluation above 5.5$ while its currently trading at 3.6 $ expecting profiting from MRNA and PFE patent royalties , currently touching rising trend line and it could be a good entry to start accumulating

Trade fechado: objetivo atingido

⋅ 21 de Jan de 2021 19:37

take profit at 4 and 4.5

Trend Analysis Wave Analysis

Mais